Sign in
Taking people in United StatesNo phase

Sympathetic Overactivity in Post-traumatic Stress Disorder

Key facts

Who runs it
Emory University
Where
Decatur, United StatesSee the site
Trial code
Status
Recruiting
People taking part
120 people, planned
Started
Jul 2012
Expected to end
Dec 2027
Type of study
Interventional, 4 groupsOne group gets a sham (pretend) treatment, for comparison.
Treatments tested
  • Device-Guided Breathing (DGB)
  • Sham DGB
  • Transcutaneous Vagal Nerve Stimulation (tVNS)
  • Sham tVNS
Record updated
15 January 2026

Who can take part

Age
18 years to 65 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • prehypertensive and normotensive veterans with PTSD, and prehypertensive and normotensive veterans without PTSD (controls)

Who cannot take part

  • illicit drug use within the last 6 months
  • medications known to affect SNS (clonidine)
  • treatment with monoamine oxidase (MAO) inhibitors within the last 14 days
  • heart or vascular disease
  • any serious systemic disease
  • excessive alcohol use (>2 drinks per day)
  • pregnancy
  • autonomic dysfunction

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 65 years old?

This trial is currently available in United States.

  • Atlanta VA Medical CenterDecatur, United StatesContact: Deirdre Dixon, MSTaking people

About the trial

What the trial wants to find out

Post-traumatic stress disorder (PTSD) is a highly prevalent anxiety disorder that is associated with an increased risk of cardiovascular (CV) disease and hypertension. One potential mechanism is overactivation of the sympathetic nervous system (SNS), both at rest and particularly during stress. This study will evaluate whether 8 weeks of daily DGB therapy or transcutaneous vagus nerve stimulation (tVNS) therapy improves SNS activity at rest and during stress.

The 4 groups in the trial

  • Device-guided Breathing (DGB)Treatment being tested

    Participants randomized to the DGB group use a device to guide their breathing to a slow breathing rate.

  • Sham DGBSham treatment, for comparison

    Participants randomized to the sham DGB group use a device identical to the DGB device but respiratory rates are not guided lower than the physiological rate.

  • Transcutaneous Vagal Nerve Stimulation (tVNS)Treatment being tested

    Participants randomized to use a tVNS device to deliver mild electrical stimulation to the vagal nerve.

  • Sham tVNSSham treatment, for comparison

    Participants randomized to use the sham tVNS device which vibrates but does not stimulate the vagal nerve.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Mechanisms of Sympathetic Overactivity in Post-traumatic Stress Disorder
Criteria questions
Built from NCT01627301, who can take part
Record updated
15 January 2026